CVC raised Recordati bid from EUR 51.29 to EUR 53.00 for Recordati stock

Published on 10/09/2026 at 12:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The offer includes EUR 0.71 dividend per share. Recordati stock costs EUR 53.03 on October 9, 2026 versus EUR 53.03 prior close, unchanged.

Key points in brief

CVC raised its Recordati takeover offer from EUR 51.29 to EUR 53.00 per share on October 6, 2026.
The acceptance deadline was extended to October 23, 2026, with payment scheduled for November 2, 2026.
Recordati stock was EUR 53.03 at Lang & Schwarz on October 9, 2026, unchanged from the prior close.
Banca Akros and Equita cited targets of EUR 65.00 and EUR 69.00, respectively.

Bauhaus-Poster mit geometrischen Formen und dem Wort PHARMA in kräftigen Farben — Recordati S.p.A. (IT0003828271) wird hier als Pharma-Unternehmen durch ein geometrisches Bauhaus-Poster mit Sektor-Kürzel symbolisiert, Illustration mit AI erstellt.

Recordati stock (ISIN IT0003828271) was EUR 53.03 at Lang & Schwarz on October 9, 2026 at 12:32 p.m. CEST, unchanged from the prior close. On October 6, 2026, CVC Capital Partners and Groupe Bruxelles Lambert raised the takeover offer from EUR 51.29 to EUR 53.00 per share, according to Reuters.

Three dates define the transaction

On July 29, 2026, Recordati reported first-half revenue of EUR 1.40 billion, up 6.60 percent, while adjusted net income rose 6.70 percent to EUR 349.90 million, according to Yahoo Finance. On September 1, 2026, Palliser Capital urged the board to reject the original EUR 51.29 offer and seek at least EUR 60.00 per share, as reported by Finanznachrichten. The current event came on October 6, when the consortium set EUR 53.00 as its best and final cash offer and included EUR 0.71 of the 2025 dividend in a total consideration of EUR 53.71, Reuters reported.

What does the bid mean for Recordati stock?

The market price stood EUR 0.03, or 0.06 percent, above the EUR 53.00 bid on October 9, 2026. That narrow spread leaves the offer terms and the acceptance timetable as the immediate reference points, rather than a broad repricing of the operating business.

The revised offer values the shares covered by the transaction at up to EUR 10.52 billion, based on 198.50 million shares, according to Investing.com. Reuters said shareholders representing 49.79 percent of Recordati capital had tendered shares by October 5, while CVC already held 46.80 percent.

Dates set the next decision points

The acceptance period now ends on October 23, 2026, and payment for tendered shares is scheduled for November 2, 2026, Reuters reported. Banca Akros kept a EUR 65.00 target and Equita cited EUR 69.00, according to Il Sole 24 ORE. Against the EUR 53.03 market price, those targets imply 22.57 percent and 30.11 percent upside, respectively, but they represent analyst assessments rather than terms of the bid.

Stock stays close to EUR 53.00

Recordati stock was trading at EUR 53.03 at Lang & Schwarz on October 9, 2026 at 12:32 p.m. CEST, versus the EUR 53.03 prior close at Lang & Schwarz. The continuously updated real-time quote of Recordati stock.